PCMA and NACDS respond to PBM reform legislation in Illinois
The legislation includes banning spread pricing and requiring PBMs to pass 100% of manufacturer rebates to health plans or patients.
PCMA
PCMA supports FTC/DOJ listening session on Big Pharma patent abuse
PCMA voiced support for a series of legislative and regulatory reforms.
PCMA backs bipartisan push to eliminate biosimilar red tape
PCMA hailed the measure as a critical step toward fostering greater market competition and reducing drug costs.
PCMA sues Arkansas over PBM law
PCMA argues the law is unconstitutional and may disrupt access to mail-order and specialty medications.
Prime Therapeutics’ Mostafa Kamal becomes PCMA board chair
Kamal succeeds David Joyner, executive vice president of CVS Health and president of CVS Caremark, who completed his term as PCMA’s board chairman.